Plus   Neg

Anika Therapeutics Inc. (ANIK) Is Surging On Q2 Results

Anika Therapeutics Inc. (ANIK) reported second quarter EPS of $0.68 after the close Wednesday, compared to $0.76 in the prior year period.

Anika Therapeutics gapped open higher Thursday and has spiked to the upside in early trade. Shares are now up 10.41 at $44.39. The stock has surged to over a 1-month high.

For comments and feedback contact: editorial@rttnews.com

Business News

Follow RTT